Difference between revisions of "Medical liver disease"

Jump to navigation Jump to search
m
replace DCHH
m
m (replace DCHH)
Line 172: Line 172:


===Epidemiology===
===Epidemiology===
*Female>male (~9:1).<ref>DCHH P.162.</ref>
*Female>male (~9:1).<ref>{{Ref DCHH|162}}</ref>
*Usually middle age.
*Usually middle age.
*Associated with other autoimmune conditions (Sjogren's syndrome, progressive systemic sclerosis, celiac).
*Associated with other autoimmune conditions (Sjogren's syndrome, progressive systemic sclerosis, celiac).
Line 203: Line 203:
*[http://www.gidesigns.net/images/MC-copper-flower-garland-L.jpg Garland - wreath of flowers (gidesigns.net)].
*[http://www.gidesigns.net/images/MC-copper-flower-garland-L.jpg Garland - wreath of flowers (gidesigns.net)].


DDx:<ref>DCHH P.163.</ref>
DDx:<ref>{{Ref DCHH|163}}</ref>
*Sarcoidosis (if granulomas present).
*Sarcoidosis (if granulomas present).
*PSC, viral hepatitis, AIH, drugs, Hodgkin's lymphoma<ref name=pmid19131796>Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature. Pass AK, McLin VA, Rushton JR, Kearney DL, Hastings CA, Margolin JF. J Pediatr Hematol Oncol. 2008 Dec;30(12):976-80. PMID 19131796.</ref>
*PSC, viral hepatitis, AIH, drugs, Hodgkin's lymphoma<ref name=pmid19131796>Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature. Pass AK, McLin VA, Rushton JR, Kearney DL, Hastings CA, Margolin JF. J Pediatr Hematol Oncol. 2008 Dec;30(12):976-80. PMID 19131796.</ref>
Line 345: Line 345:
Microscopic:
Microscopic:
*Non-specific findings.
*Non-specific findings.
**+/-Eosinophils.<ref>DCHH P.166.</ref>
**+/-Eosinophils.<ref>{{Ref DCHH|166}}</ref>
**+/-Steatosis - periportal macrovesicular, microvesicular.
**+/-Steatosis - periportal macrovesicular, microvesicular.


48,541

edits

Navigation menu